Laura Mackay is awarded the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research in Mid-Career

Laura Mackay Awarded the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research Mid-Career

Laura Mackay has been selected as the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research in recognition for her outstanding work on memory T cell populations and the cytokines that control them. Professor Mackay’s discoveries have resulted in dramatic paradigm shifts and have contributed enormously to the T cell field, spawning a new focus on tissue immunity. Her accomplishments are shaping and redefining how we understand cellular immune responses and have driven a new field of T cell immunology. These accomplishments indeed far exceed her designated “mid-career” stage.

Nomination/Application Form 2024 ICIS Young Investigator, Post-doc & Graduate Student Awards

ICIS Young Investigator Awards Nomination/Application Deadline Extended to Monday, April 8th!

Nomination/Application Form 2024 ICIS Young Investigator, Post-doc & Graduate Student Awards – Deadline extended to Monday, April 8th for the following Awards: ICIS-Regeneron New Investigator Awards for Excellence in Cytokine & Interferon Research (formerly the Milstein Young Investigator Awards) sponsored by Regeneron; Christina Fleischmann Award for Excellence in Cytokine & Interferon Research, recognizing a Young Woman Investigator sponsored by the Fleishmann Family; Sidney & Joan Pestka Graduate and Post-Graduate Awards sponsored by PBL Assay Science and The ICIS-Pfizer Amanda Proudfoot Award for Advances in Chemokine Biology by a Trainee sponsored by Pfizer

Howard Young

ICIS-Distinguished Service Award to be Renamed in Honor of Howard Young, Ph.D.

Today, the governing council of the International Cytokine & Interferon Society (ICIS) announced the Society’s ICIS-Distinguished Service Award would henceforth be known as the ICIS-Howard A. Young Distinguished Service Award in recognition of the extraordinary contributions Dr. Young has given to the ICIS and its predecessor society, the International Society for Interferon and Cytokine Research (ISICR).

“It’s hard to imagine anyone ever doing more for our society than Howard Young,” said current ICIS President, Sarah Gaffen. “Starting with his leadership of the ISICR, the countless committees on which he served, his stewardship of Signals+, he is the epitome of service and the spirit that permeates everything we do.”